<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Felodipine does not affect mortality in heart failure</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Felodipine does not affect mortality in heart failure</h1>
<div class="graphic"><div class="figure"><div class="ttl">Felodipine does not affect mortality in heart failure</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">In V-HeFT III, felodipine SR or placebo was randomly administered to 450 patients with chronic heart failure receiving optimal therapy with enalapril and diuretics. Mortality (13.8 versus 12.8 percent) did not differ significantly between the two groups.</div><div class="graphic_reference">Data from: Cohen JN, Ziesche S, Smith R, et al, for the Vasodilator-Heart Failure Trial (V-HeFT) Study Group, Circulation 1997; 96:856.</div><div id="graphicVersion">Graphic 78557 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
